WeVote

Bill

Bill

AB 2009

Blood banks and plasma centers.

2025-2026 Regular Session Introduced by Catherine Blakespear and 3 co-sponsors

AB 2009 regulates California blood banks and plasma centers, potentially affecting blood supply operations, donor policies, and facility compliance requirements.

Read third time. Passed. Ordered to the Senate.
0
WeVote Research Nonpartisan
Bill Summary · AB 2009

Legislative bill overview

AB 2009 addresses regulations and operations of blood banks and plasma centers in California. The bill has recently been introduced and is currently in its early procedural stages, having just been read for the first time and sent to print for committee consideration.

Why is this important

Blood banks and plasma centers are critical infrastructure for the state's blood supply and plasma-derived therapies. Regulatory changes to these facilities can affect donation rates, product safety, operational costs, and access to life-saving transfusions and medical treatments for Californians.

Potential points of contention

  • Operational burden vs. safety: Any new regulations could increase compliance costs for facilities, potentially affecting smaller blood banks' viability while supporters argue stronger oversight protects patients
  • Donor incentives and supply: Changes to compensation or donation policies could either increase the blood supply or reduce donor participation depending on provisions
  • Federal-state coordination: Blood products are federally regulated; unclear how state-level requirements interact with FDA standards and whether they create redundancy or gaps

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.